10x Genomics to Present at the Morgan Stanley 19th Annual Global Healthcare Conference
10x Genomics, Inc. (TXG)
Last 10x genomics, inc. earnings: 2/18 04:01 pm
Check Earnings Report
Company Research
Source: GlobeNewswire
PLEASANTON, Calif., Aug. 31, 2021 (GLOBE NEWSWIRE) -- 10x Genomics, Inc. (Nasdaq: TXG), today announced the company will be participating in the Morgan Stanley 19th Annual Global Healthcare Conference. 10x Genomics’ management is scheduled to present on Monday, September 13th, at 2:45 p.m. Eastern Time/11:45 a.m. Pacific Time. Interested parties may access a live and archived webcast of the presentation on the “Investors” section of the company’s website at: https://investors.10xgenomics.com/. About 10x Genomics 10x Genomics is a life science technology company building products to interrogate, understand and master biology to advance human health. The company’s integrated solutions include instruments, consumables and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. 10x Genomics products have been adopted by researchers around the world including in all of the top 100 global research institutions as ranked by Nature in 2
Show less
Read more
Impact Snapshot
Event Time:
TXG
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TXG alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TXG alerts
High impacting 10x Genomics, Inc. news events
Weekly update
A roundup of the hottest topics
TXG
News
- 10x Genomics, Inc. (NASDAQ: TXG) had its price target lowered by analysts at Deutsche Bank Aktiengesellschaft from $60.00 to $55.00. They now have a "buy" rating on the stock.MarketBeat
- Vizgen Issued a New US Patent for Its MERFISH Technology [Yahoo! Finance]Yahoo! Finance
- 10x Genomics to Report First Quarter 2024 Financial Results on April 30, 2024PR Newswire
- 10x Genomics, Inc. (NASDAQ: TXG) had its price target lowered by analysts at Barclays PLC from $55.00 to $45.00. They now have an "overweight" rating on the stock.MarketBeat
- 10x Genomics Commercially Launches Visium HD Spatial Gene Expression Assay [Yahoo! Finance]Yahoo! Finance
TXG
Earnings
- 2/15/24 - Miss
TXG
Sec Filings
- 4/12/24 - Form PRE
- 3/25/24 - Form 4
- 3/25/24 - Form 4
- TXG's page on the SEC website